Check out our iPub® Frontiers in Endometrial Cancer: Emerging Pathways and Targets to learn about the current treatment options and patient care journey in advanced or recurrent endometrial cancer.https://bit.ly/4aYlG81
About us
OncLive is the official website for the Intellisphere, LLC Oncology Specialty Group, which publishes OncologyLive, Urologists in Cancer Care, Oncology Nursing News, and Oncology Fellows. The mission of OncLive is to arm oncology professionals with the resources and information they need to provide the best patient care. We cover every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. OncLive allows the Oncology Specialty Group to add features and tools not possible with print, such as social media feeds, breaking news, and live coverage from major oncology meetings.
- Website
-
http://onclive.com
External link for OncLive
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Headquarters
- Cranbury, NJ
- Type
- Privately Held
Locations
-
Primary
Get directions
2 Clarke Dr
Cranbury, NJ 08512, US
Employees at OncLive
-
Chelsea DeLisa
Senior National Account Manager at OncLive, an MJH Life Sciences Brand
-
Chandler Park, M.D., F.A.C.P.
Award Winning Oncologist| 3x NEJM Published Author| ASCO Faculty|Advisory Dean/Clinical Professor UofL Medical School|Kentucky Leader ASCO ASH NCCN…
-
Morgan Burum
Director of Sales
-
Gabrielle Gelchion
National Account Manager, Onclive Events™
Updates
-
Check out our iPub® to hear experts discuss advanced ovarian cancer today. #sponsored https://lnkd.in/eGDfAyFv For US Healthcare Professionals Only
-
-
The BLA seeking approval for remestemcel-L for children with steroid-refractory acute graft-vs-host-disease has been resubmitted to the FDA. #oncology https://lnkd.in/eifn5PSk
-
Jacob Sands, MD, shares updated data from the phase 3 TROPION-Lung01 trial of datopotamab deruxtecan vs docetaxel in nonsquamous non–small cell lung cancer recently presented at the 2024 European Lung Cancer Congress. https://lnkd.in/e85tyyZe
Datopotamab Deruxtecan (Dato-DXd) in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) – Nonsquamous (NSQ) Histology in the Phase 3 TROPION-Lung01 Trial
onclive.com
-
Excited for the upcoming #MedicalSpotlight on July 13th with MedNews Week! Join us to explore Carving Out A Career in Medical Education with Sam Brondfield, MD, MA. Register now: https://ow.ly/kuWx50Sxk9e
-
-
The FDA has granted fast track designation to ADI-270 for advanced clear cell renal cell carcinoma after an immune checkpoint inhibitor and VEGF inhibitor. #oncology #RCC https://lnkd.in/evcE9dKN
ADI-270 Earns FDA Fast Track Designation for Pretreated Advanced ccRCC
onclive.com
-
A panel of hematologist-oncologists provides an overview of the diagnosis and treatment of myelodysplastic syndromes and offers comprehensive insights on the evolving treatment landscape. #hematology https://lnkd.in/eEBgs2rN
First-Line Treatment of Lower-Risk MDS with Symptomatic Anemia
onclive.com
-
Join the conversation at the 15th Annual Ruesch Center Symposium as we delve into the current landscape of therapies, basic and translational science, and early detection. #GIcancer Register: https://ow.ly/r1Mk50SlhX0 Lombardi Comprehensive Cancer Center MedStar Georgetown University Hospital The Ruesch Center for the Cure of Gastrointestinal Cancers
-
-
Here is your guide to the important regulatory decisions made by the FDA in June 2024. #oncology https://lnkd.in/e-ifGd55
OncLive’s June Roundup of Key FDA Approvals in Oncology
onclive.com
-
Tune into our new series: Minutes With Markman! Listen in as Maurie Markman, MD, covers the broad landscape of info in #Oncology. This week, he discusses the evolution of breast and lung cancer management. Watch only on YouTube: https://lnkd.in/ejJJQtfF
-